Patents by Inventor John Burnes
John Burnes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11759557Abstract: Methods for monitoring patient parameters and blood fluid removal system parameters include identifying those system parameters that result in improved patient parameters or in worsened patient parameters. By comparing the patient's past responses to system parameters or changes in system parameters, a blood fluid removal system may be able to avoid future use of parameters that may harm the patient and may be able to learn which parameters are likely to be most effective in treating the patient in a blood fluid removal session.Type: GrantFiled: September 28, 2020Date of Patent: September 19, 2023Assignee: Mozarc Medical US LLCInventors: Martin Gerber, John Burnes, SuPing Lyu, Venkatesh R. Manda, Bryant Pudil
-
Patent number: 11471100Abstract: A system and method for synchronizing patient medical parameters and dialysis parameters. The system and related method allow for the determination of the effect of dialysis on patient health. The invention also allows for the determination of whether observed patient health effects are due to specific dialysis parameters and for making necessary changes to the dialysis parameters in order to improve patient health.Type: GrantFiled: February 28, 2020Date of Patent: October 18, 2022Assignee: Medtronic, Inc.Inventors: John Burnes, VenKatesh Manda, Tico Blumenthal, Orhan Soykan
-
Patent number: 11471099Abstract: A system and method for synchronizing patient medical parameters and dialysis parameters. The system and related method allow for the determination of the effect of dialysis on patient health. The invention also allows for the determination of whether observed patient health effects are due to specific dialysis parameters and for making necessary changes to the dialysis parameters in order to improve patient health.Type: GrantFiled: February 28, 2020Date of Patent: October 18, 2022Assignee: Medtronic, Inc.Inventors: John Burnes, VenKatesh Manda, Tico Blumenthal, Orhan Soykan
-
Patent number: 11395868Abstract: Systems and methods are provided for determining an estimated risk of arrhythmia during or after dialysis based on changes in serum potassium concentration of a patient and an amount of fluid removed from the patient during dialysis. The systems and methods allow for a determination of a risk that arrhythmia will occur due to the changes in potassium and fluid volume of a patient during dialysis, and for optimizing a dialysis prescription in order to minimize the risk of arrhythmia.Type: GrantFiled: May 14, 2019Date of Patent: July 26, 2022Assignee: Medtronic, Inc.Inventors: Amy Roettger, VenKatesh R. Manda, John Burnes, Rebecca Poindexter, Martin T. Gerber
-
Patent number: 10967112Abstract: Methods for monitoring patient parameters and blood fluid removal system parameters include identifying those system parameters that result in improved patient parameters or in worsened patient parameters. By comparing the patient's past responses to system parameters or changes in system parameters, a blood fluid removal system may be able to avoid future use of parameters that may harm the patient and may be able to learn which parameters are likely to be most effective in treating the patient in a blood fluid removal session.Type: GrantFiled: September 1, 2017Date of Patent: April 6, 2021Assignee: Medtronic, Inc.Inventors: Martin Gerber, John Burnes, SuPing Lyu, VenKatesh R. Manda, Bryant Pudil
-
Publication number: 20210008265Abstract: Methods for monitoring patient parameters and blood fluid removal system parameters include identifying those system parameters that result in improved patient parameters or in worsened patient parameters. By comparing the patient's past responses to system parameters or changes in system parameters, a blood fluid removal system may be able to avoid future use of parameters that may harm the patient and may be able to learn which parameters are likely to be most effective in treating the patient in a blood fluid removal session.Type: ApplicationFiled: September 28, 2020Publication date: January 14, 2021Inventors: Martin Gerber, John Burnes, SuPing Lyu, VenKatesh R. Manda, Bryant Pudil
-
Publication number: 20200289056Abstract: A system and method for synchronizing patient medical parameters and dialysis parameters. The system and related method allow for the determination of the effect of dialysis on patient health. The invention also allows for the determination of whether observed patient health effects are due to specific dialysis parameters and for making necessary changes to the dialysis parameters in order to improve patient health.Type: ApplicationFiled: February 28, 2020Publication date: September 17, 2020Applicant: Medtronic, IncInventors: John Burnes, VenKatesh Manda, Tico Blumenthal, Orhan Soykan
-
Patent number: 10743779Abstract: A system and method for controlling a monitoring mode or treatment mode of an implantable medical device based on the detection of an external signal. The system and related method allow for more frequent monitoring of medical parameters at times where more frequent monitoring is necessary, such as during or after a dialysis session, with less frequent monitoring at other times, allowing for a more efficient medical device. The invention also allows for the frequency or mode of treatment by the implantable medical device, or the transmission of data from the implantable medical device to be controlled based on the external signal.Type: GrantFiled: February 2, 2016Date of Patent: August 18, 2020Assignee: Medtronic, Inc.Inventors: John Burnes, Rebecca Poindexter, Daniel Bloomberg, Christopher M. Hobot, Roland C. Maude-Griffin
-
Publication number: 20200245927Abstract: A system and method for synchronizing patient medical parameters and dialysis parameters. The system and related method allow for the determination of the effect of dialysis on patient health. The invention also allows for the determination of whether observed patient health effects are due to specific dialysis parameters and for making necessary changes to the dialysis parameters in order to improve patient health.Type: ApplicationFiled: February 28, 2020Publication date: August 6, 2020Applicant: Medtronic, Inc.Inventors: John Burnes, Venkatesh Manda, Tico Blumenthal, Orhan Soykan
-
Patent number: 10617349Abstract: A system and method for synchronizing patient medical parameters and dialysis parameters. The system and related method allow for the determination of the effect of dialysis on patient health. The invention also allows for the determination of whether observed patient health effects are due to specific dialysis parameters and for making necessary changes to the dialysis parameters in order to improve patient health.Type: GrantFiled: November 26, 2014Date of Patent: April 14, 2020Assignee: MEDTRONIC, INC.Inventors: John Burnes, VenKatesh Manda, Tico Blumenthal, Orhan Soykan
-
Publication number: 20190262529Abstract: Systems and methods are provided for determining an estimated risk of arrhythmia during or after dialysis based on changes in serum potassium concentration of a patient and an amount of fluid removed from the patient during dialysis. The systems and methods allow for a determination of a risk that arrhythmia will occur due to the changes in potassium and fluid volume of a patient during dialysis, and for optimizing a dialysis prescription in order to minimize the risk of arrhythmia.Type: ApplicationFiled: May 14, 2019Publication date: August 29, 2019Inventors: Amy ROETTGER, VenKatesh R. MANDA, John BURNES, Rebecca POINDEXTER, Martin T. GERBER
-
Patent number: 10335534Abstract: Systems and methods are provided for determining an estimated risk of arrhythmia during or after dialysis based on changes in serum potassium concentration of a patient and an amount of fluid removed from the patient during dialysis. The systems and methods allow for a determination of a risk that arrhythmia will occur due to the changes in potassium and fluid volume of a patient during dialysis, and for optimizing a dialysis prescription in order to minimize the risk of arrhythmia.Type: GrantFiled: October 25, 2016Date of Patent: July 2, 2019Assignee: Medtronic, Inc.Inventors: Amy Roettger, VenKatesh R. Manda, John Burnes, Rebecca Poindexter, Martin T. Gerber
-
Patent number: 10293092Abstract: Methods include monitoring indicators of blood pH or blood electrolyte levels during a blood fluid removal session and adjusting concentrations of pH buffers or electrolytes in dialysate or replacement fluid used during the session based on the monitored indicators. Blood fluid removal systems may employ sensors that monitor blood pH or electrolyte levels to adjust the fluid parameters during a blood fluid removal session.Type: GrantFiled: August 18, 2015Date of Patent: May 21, 2019Assignee: MEDTRONIC, INC.Inventors: Martin Gerber, John Burnes, Suping Lyu, VenKatesh R. Manda, Bryant Pudil
-
Patent number: 10179198Abstract: Methods include monitoring indicators of blood pH or blood electrolyte levels during a blood fluid removal session and adjusting concentrations of pH buffers or electrolytes in dialysate or replacement fluid used during the session based on the monitored indicators. Blood fluid removal systems may employ sensors that monitor blood pH or electrolyte levels to adjust the fluid parameters during a blood fluid removal session.Type: GrantFiled: August 18, 2015Date of Patent: January 15, 2019Assignee: MEDTRONIC, INC.Inventors: Martin Gerber, John Burnes, Suping Lyu, VenKatesh R. Manda, Bryant Pudil
-
Publication number: 20180263511Abstract: A system and method for controlling a monitoring mode or treatment mode of an implantable medical device based on the detection of an external signal. The system and related method allow for more frequent monitoring of medical parameters at times where more frequent monitoring is necessary, such as during or after a dialysis session, with less frequent monitoring at other times, allowing for a more efficient medical device. The invention also allows for the frequency or mode of treatment by the implantable medical device, or the transmission of data from the implantable medical device to be controlled based on the external signal.Type: ApplicationFiled: February 2, 2016Publication date: September 20, 2018Applicant: Medtronic, Inc.Inventors: John Burnes, Rebecca Poindexter, Daniel Bloomberg, Christopher M. Hobot, Roland C. Maude-Griffin
-
Patent number: 9968721Abstract: A method includes monitoring an indicator of fluid volume of a patient via a sensor device, and setting an initial fluid volume removal prescription for a blood fluid removal session based on the monitored indicator of fluid volume. The method may further include transmitting data regarding the indicator of fluid volume from the implantable sensor device to fluid removal device. The system includes a blood fluid removal device and control electronics configured to set the initial fluid removal volume and rate prescription. In some embodiments, the fluid removal device sets or calculated the initial fluid volume removal prescription based on the data received from the implantable sensor. The indicator of fluid volume may be an indicator of tissue fluid volume or an indicator of blood fluid volume.Type: GrantFiled: November 26, 2014Date of Patent: May 15, 2018Assignee: MEDTRONIC, INC.Inventors: Martin Gerber, John Burnes, Suping Lyu, VenKatesh R. Manda, Bryant Pudil
-
Publication number: 20170361006Abstract: Methods for monitoring patient parameters and blood fluid removal system parameters include identifying those system parameters that result in improved patient parameters or in worsened patient parameters. By comparing the patient's past responses to system parameters or changes in system parameters, a blood fluid removal system may be able to avoid future use of parameters that may harm the patient and may be able to learn which parameters are likely to be most effective in treating the patient in a blood fluid removal session.Type: ApplicationFiled: September 1, 2017Publication date: December 21, 2017Inventors: Martin Gerber, John Burnes, SuPing Lyu, VenKatesh R. Manda, Bryant Pudil
-
Patent number: 9750862Abstract: Methods for monitoring patient parameters and blood fluid removal system parameters include identifying those system parameters that result in improved patient parameters or in worsened patient parameters. By comparing the patient's past responses to system parameters or changes in system parameters, a blood fluid removal system may be able to avoid future use of parameters that may harm the patient and may be able to learn which parameters are likely to be most effective in treating the patient in a blood fluid removal session.Type: GrantFiled: March 20, 2012Date of Patent: September 5, 2017Assignee: Medtronic, Inc.Inventors: Martin Gerber, John Burnes, Suping Lyu, VenKatesh R. Manda, Bryant Pudil
-
Publication number: 20170128657Abstract: Systems and methods are provided for determining an estimated risk of arrhythmia during or after dialysis based on changes in serum potassium concentration of a patient and an amount of fluid removed from the patient during dialysis. The systems and methods allow for a determination of a risk that arrhythmia will occur due to the changes in potassium and fluid volume of a patient during dialysis, and for optimizing a dialysis prescription in order to minimize the risk of arrhythmia.Type: ApplicationFiled: October 25, 2016Publication date: May 11, 2017Inventors: Amy ROETTGER, VenKatesh R. MANDA, John BURNES, Rebecca POINDEXTER, Martin T. GERBER
-
Patent number: 9642960Abstract: A method includes monitoring an indicator of fluid volume of a patient via a sensor device, and setting an initial fluid volume removal prescription for a blood fluid removal session based on the monitored indicator of fluid volume. The method may further include transmitting data regarding the indicator of fluid volume from the implantable sensor device to fluid removal device. The system includes a blood fluid removal device configured to set the initial fluid removal volume and rate prescription. In some embodiments, the fluid removal device sets or calculated the initial fluid volume removal prescription based on the data received from the implantable sensor. The indicator of fluid volume may be an indicator of tissue fluid volume or an indicator of blood fluid volume.Type: GrantFiled: November 26, 2014Date of Patent: May 9, 2017Assignee: MEDTRONIC, INC.Inventors: Martin Gerber, John Burnes, Suping Lyu, Manda R. VenKatesh, Bryant Pudil